Andrei Pikalov

Andrei Pikalov

Psychiatry

25 Laguna Forest Trail
Palm Coast, FL 32164

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

A real-world data analysis of electronic health records to investigate the associations of predominant negative symptoms with healthcare resource utilisation, costs and treatment patterns among patients with schizophrenia.

A real-world data analysis of electronic health records to investigate the associations of predominant negative symptoms with healthcare resource utilisation, costs and treatment patterns among patients with schizophrenia.

Journal: BMJ open

Published: August 01, 2024

The Effect of Lurasidone on Anxiety Symptoms in Patients With Bipolar Depression: A Post Hoc Analysis.

The Effect of Lurasidone on Anxiety Symptoms in Patients With Bipolar Depression: A Post Hoc Analysis.

Journal: The Journal of clinical psychiatry

Published: June 20, 2023

Lurasidone and risk of metabolic syndrome: results from short and long-term studies in patients with bipolar depression.

Lurasidone and risk of metabolic syndrome: results from short and long-term studies in patients with bipolar depression.

Journal: CNS spectrums

Published: March 24, 2023

Implementing Digital Technologies in Clinical Trials: Lessons Learned.

Implementing Digital Technologies in Clinical Trials: Lessons Learned.

Journal: Innovations in clinical neuroscience

Published: August 12, 2022

Sleep Disturbance, Irritability, and Response to Lurasidone Treatment in Children and Adolescents with Bipolar Depression.

Sleep Disturbance, Irritability, and Response to Lurasidone Treatment in Children and Adolescents with Bipolar Depression.

Journal: Current neuropharmacology

Published: April 15, 2022

Short-term Efficacy and Safety of Lurasidone Versus Placebo in Antipsychotic-Naïve vs. Previously Treated Adolescents with an Acute Exacerbation of Schizophrenia.

Short-term Efficacy and Safety of Lurasidone Versus Placebo in Antipsychotic-Naïve vs. Previously Treated Adolescents with an Acute Exacerbation of Schizophrenia.

Journal: European psychiatry : the journal of the Association of European Psychiatrists

Published: March 24, 2022

Efficacy and safety of lurasidone in schizophrenia: pooled analysis of European results from double-blind, placebo-controlled 6-week studies.

Efficacy and safety of lurasidone in schizophrenia: pooled analysis of European results from double-blind, placebo-controlled 6-week studies.

Journal: International clinical psychopharmacology

Published: March 11, 2022

Tolerability, Safety, and Effectiveness of Two Years of Treatment with Lurasidone in Children and Adolescents with Bipolar Depression.

Tolerability, Safety, and Effectiveness of Two Years of Treatment with Lurasidone in Children and Adolescents with Bipolar Depression.

Journal: Journal of child and adolescent psychopharmacology

Published: July 29, 2021

Safety and effectiveness of lurasidone in adolescents with schizophrenia: results of a 2-year, open-label extension study -- CORRIGENDUM.

Safety and effectiveness of lurasidone in adolescents with schizophrenia: results of a 2-year, open-label extension study -- CORRIGENDUM.

Journal: CNS spectrums

Published: May 17, 2021

Efficacy and safety of lurasidone in adolescents and young adults with schizophrenia: A pooled post hoc analysis of double-blind, placebo-controlled 6-week studies.

Efficacy and safety of lurasidone in adolescents and young adults with schizophrenia: A pooled post hoc analysis of double-blind, placebo-controlled 6-week studies.

Journal: European psychiatry : the journal of the Association of European Psychiatrists

Published: May 10, 2021

Long-term safety and effectiveness of open-label lurasidone in antipsychotic-Naïve versus previously treated adolescents with Schizophrenia: A post-hoc analysis.

Long-term safety and effectiveness of open-label lurasidone in antipsychotic-Naïve versus previously treated adolescents with Schizophrenia: A post-hoc analysis.

Journal: Schizophrenia research

Published: April 08, 2021

Efficacy and safety of eslicarbazepine acetate as a first or later adjunctive therapy in patients with focal seizures.

Efficacy and safety of eslicarbazepine acetate as a first or later adjunctive therapy in patients with focal seizures.

Journal: Epilepsy research

Published: December 03, 2020

Showing 1-12 of 53

Last Updated: 09/26/2026